Laurus Labs informs about company updates

19 Aug 2017 Evaluate

Laurus Labs has informed that US Food and Drug Administration (USFDA) has completed inspection of API facilities in Unit 1 and 3 in Parawada, Visakhapatnam, Andhra Pradesh, with two observations. This is a regular surveillance audit by USFDA, and the observations are procedural in nature and no data integrity issues were observed.

The above information is a part of company’s filings submitted to BSE.

Laurus Labs Share Price

586.80 5.35 (0.92%)
18-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1748.60
Dr. Reddys Lab 1164.70
Cipla 1508.70
Lupin 2035.30
Zydus Lifesciences 903.10
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...